Cases & Deals

SymBiosis participates in €18 million Series B financing round of MaaT Pharma

Clients SymBiosis, LLC

Jones Day advised SymBiosis LLC, as lead investor, in connection with the €18 million Series B round of financing of MaaT Pharma, a French clinical-stage company developing microbiome-based biotherapeutics.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.